VYGR   $3.77  0.80% Market Open

Voyager Therapeutics, Inc.
Total Cash 371.02M
totalCashPerShare 6.804
EBITDA -1.78M
Total Debt 46.94M
quickRatio 9.326
currentRatio 9.508
Total Revenue 143.77M
debtToEquity 13.995
Revenue/Share 2.837
ROA -0.0110599995
ROE 0.033770002
grossProfits
freeCashflow -506.50K
operatingCashflow -17.62M
earningsGrowth
revenueGrowth 5.095
grossMargins 0.21288
ebitdaMargins -0.012410001
operatingMargins -0.50798
profitMargins 0.06276
enterpriseValue 38.57M
forwardPE -4.3333335
floatShares 36.24M
sharesOutstanding 54.53M
sharesShort 3.45M
sharesShortPriorMonth 4.25M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.17%
heldPercentInstitutions 0.69%
Short Ratio help_outline 5.96%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 6.158
Price To Book help_outline 1.18
earningsQuarterlyGrowth
netIncomeToCommon 9.02M
trailingEps 0.27%
forwardEps -1.68%
enterpriseToEbitda -21.62
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.45 3Q 2024
institutionsCount 181
lastUpdated Nov. 7, 2024, 2:23 a.m.